Literature DB >> 19757182

RNA interference: a potent technology in studying and modulating of dendritic cells, and potential in clinical therapy.

Fang Cheng1, Song He.   

Abstract

RNA interference (RNAi) is a natural process by which small interfering RNA duplex directs sequencespecific post-transcriptional silencing of homologous genes by binding to its complementary mRNA and triggering its elimination. The history of RNAi has only about two decades, however, further studies have revealed that it is a potent method of gene silencing that has developed rapidly over the past few years as a result of its extensive importance in the study of genetics, molecular biology and physiology. RNAi technology has also recently yielded significant insight into dendritic cells (DCs) by helping to elucidate numerous mechanisms that regulate the development, activation and function of cells that mediate immunity. In addition, because of its ability to suppress gene expression effectively, this technique may be used to regulate the immune response for clinical purposes. As the key antigen presenting cells, DCs play a crucial part in the start of an immune response and in the enhancement and regulation of cell mediated immune reactions. The current studies indicated that targeting DCs with RNAi is a novel and effective therapeutic method for the fundamental research, and displayed great potential in clinical treatment.

Mesh:

Year:  2009        PMID: 19757182     DOI: 10.1007/s11033-009-9789-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  82 in total

1.  Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference.

Authors:  S Parrish; J Fleenor; S Xu; C Mello; A Fire
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

2.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

3.  RNA interference in mammalian cells by chemically-modified RNA.

Authors:  Dwaine A Braasch; Susan Jensen; Yinghui Liu; Kiran Kaur; Khalil Arar; Michael A White; David R Corey
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

Review 4.  The interface between innate and adaptive immunity.

Authors:  Kasper Hoebe; Edith Janssen; Bruce Beutler
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

5.  Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potency.

Authors:  Tae Woo Kim; Jin-Hyup Lee; Liangmei He; David A K Boyd; J Marie Hardwick; Chien-Fu Hung; T-C Wu
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

6.  Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function.

Authors:  Jonathan Jantsch; Dipshikha Chakravortty; Nadine Turza; Alexander T Prechtel; Björn Buchholz; Roman G Gerlach; Melanie Volke; Joachim Gläsner; Christina Warnecke; Michael S Wiesener; Kai-Uwe Eckardt; Alexander Steinkasserer; Michael Hensel; Carsten Willam
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

7.  Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.

Authors:  Hidetoshi Sumimoto; Makoto Miyagishi; Hiroyuki Miyoshi; Shizuko Yamagata; Ayako Shimizu; Kazunari Taira; Yutaka Kawakami
Journal:  Oncogene       Date:  2004-08-12       Impact factor: 9.867

Review 8.  Immunological research using RNA interference technology.

Authors:  Chih-Ping Mao; Yen-Yu Lin; Chien-Fu Hung; T-C Wu
Journal:  Immunology       Date:  2007-04-12       Impact factor: 7.397

9.  Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.

Authors:  Joacim Elmén; Håkan Thonberg; Karl Ljungberg; Miriam Frieden; Majken Westergaard; Yunhe Xu; Britta Wahren; Zicai Liang; Henrik Ørum; Troels Koch; Claes Wahlestedt
Journal:  Nucleic Acids Res       Date:  2005-01-14       Impact factor: 16.971

10.  The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development.

Authors:  Remko Schotte; Maho Nagasawa; Kees Weijer; Hergen Spits; Bianca Blom
Journal:  J Exp Med       Date:  2004-12-06       Impact factor: 14.307

View more
  2 in total

1.  Silencing CX3CR1 production modulates the interaction between dendritic and endothelial cells.

Authors:  Xiaoyan Liu; Guohong Lu; Jinfang Shen
Journal:  Mol Biol Rep       Date:  2010-04-03       Impact factor: 2.316

2.  RNAi assay in primary cells: a new method for gene function analysis in marine bivalve.

Authors:  Yanan You; Pin Huan; Baozhong Liu
Journal:  Mol Biol Rep       Date:  2012-04-28       Impact factor: 2.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.